# GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

> **NCT05391126** · NA · RECRUITING · sponsor: **Reema A. Patel** · enrollment: 178 (estimated)

## Conditions studied

- Colorectal Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT05391126
- **Lead sponsor:** Reema A. Patel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-28
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05391126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05391126, "GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT05391126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*